"Clinical Research site located in Waltham, MA conducting a variety of clinical trials, specializing in migraine. Dr. Egilius Spierings, MD, PhD"

During the past decade, MedVadis Research Corporation conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 40 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 23 clinical trials were completed. i.e. 85.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MedVadis Research Corporation" #1 sponsor was "Eli Lilly and Company" with 20 trials, followed by "Pfizer" with 9 trials sponsored, "Allergan" with 5 trials sponsored, "BioDelivery Sciences International" with 3 trials sponsored and "Purdue Pharma LP" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MedVadis Research Corporation" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Astellas Pharma Europe B.V." with 1 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "Clinvest Research, LLC" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "MedVadis Research Corporation" are "Migraine" (12 trials), "Osteoarthritis" (6 trials), "Low Back Pain" (5 trials), "Alzheimer Disease" (4 trials) and "Chronic Pain" (4 trials). Many other conditions were trialed in "MedVadis Research Corporation" in a lesser frequency.

Most popular intervention types in "MedVadis Research Corporation" are "Drug" (66 trials), "Biological" (7 trials), "Device" (3 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Buprenorphine" (3 trials), "LY3016859" (3 trials), "LY3556050" (3 trials) and "Donanemab" (2 trials). Other intervention names were less common.

The vast majority of trials in "MedVadis Research Corporation" are 69 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MedVadis Research Corporation". undefined are not yet recruiting, 12 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in MedVadis Research Corporation, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in MedVadis Research Corporation, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".